Sunshine Biopharma (SBFM) Acquisitions (2018)
Sunshine Biopharma (SBFM) posted Acquisitions of $9884.0 for Q4 2018, up 111.6% on a QoQ basis from -$85231.0 in Q3 2018.
Sunshine Biopharma (SBFM) Acquisitions (2018) Analysis & Trends
Sunshine Biopharma's Acquisitions history runs 1 years deep, the most recent figure standing at $9884.0 for Q4 2018.
- Quarterly Acquisitions changed N/A year-over-year to $9884.0 in Q4 2018, while the trailing twelve-month figure through Sep 2019 was $9884.0 (up 300.0% YoY) and the FY2022 annual result came in at $14.3 million, changed N/A from the prior year.
- Acquisitions was $9884.0 for Q4 2018 at Sunshine Biopharma, up from -$85231.0 in the prior quarter.
- Across five years, Acquisitions topped out at $75347.0 in Q2 2018 and bottomed at -$85231.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 9,884.00 |
| Sep 30, 2018 | -85,231.00 |
| Jun 30, 2018 | 75,347.00 |
| Mar 31, 2018 | 4,942.00 |